Exact Mass: 187.0797
Exact Mass Matches: 187.0797
Found 172 metabolites which its exact mass value is equals to given mass value 187.0797,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
2-Keto-6-acetamidocaproate
2-Keto-6-acetamidocaproate is an intermediate in lysine degradation. It can be generated from N6-acetyl-L-lysine. N-acetyl-lysine is an acetylated amino acid. Post-translational lysine-acetylation is one of two major modifications of lysine residues in various proteins. Acetylation of specific lysine residues in the N-terminal domains of core histones is a biochemical marker of active genes. Acetylation is now known to play a major role in eukaryotic transcription. Specifically, acetyltransferase enzymes that act on particular lysine side chains of histones and other proteins are intimately involved in transcriptional activation. N6-acetyl-L-lysine can be converted to 2-Keto-6-acetamidocaproate via the enzyme N6-acetyllysine aminotransferase and then 2-keto-6-acetamidocaproate can be reduced enzymatically to 5-acetamidovalerate. [HMDB] 2-Keto-6-acetamidocaproate is an intermediate in lysine degradation. It can be generated from N6-acetyl-L-lysine. N-acetyl-lysine is an acetylated amino acid. Post-translational lysine-acetylation is one of two major modifications of lysine residues in various proteins. Acetylation of specific lysine residues in the N-terminal domains of core histones is a biochemical marker of active genes. Acetylation is now known to play a major role in eukaryotic transcription. Specifically, acetyltransferase enzymes that act on particular lysine side chains of histones and other proteins are intimately involved in transcriptional activation. N6-acetyl-L-lysine can be converted to 2-Keto-6-acetamidocaproate via the enzyme N6-acetyllysine aminotransferase and then 2-keto-6-acetamidocaproate can be reduced enzymatically to 5-acetamidovalerate.
Amrinone
Amrinone is only found in individuals that have used or taken this drug. It is a type 3 pyridine phosphodiesterase inhibitor. It is used in the treatment of congestive heart failure.Amrinone is a phosphodiesterase inhibitor (PDE3), resulting in increased cAMP and cGMP which leads to an increase in the calcium influx like that caused by beta-agonists resulting in increased inotropic effect.
Amrinone
C - Cardiovascular system > C01 - Cardiac therapy > C01C - Cardiac stimulants excl. cardiac glycosides > C01CE - Phosphodiesterase inhibitors D004791 - Enzyme Inhibitors > D010726 - Phosphodiesterase Inhibitors > D058987 - Phosphodiesterase 3 Inhibitors C78274 - Agent Affecting Cardiovascular System > C29707 - Vasodilating Agent D002317 - Cardiovascular Agents > D002121 - Calcium Channel Blockers D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents C471 - Enzyme Inhibitor > C744 - Phosphodiesterase Inhibitor D020011 - Protective Agents > D002316 - Cardiotonic Agents D000077264 - Calcium-Regulating Hormones and Agents D049990 - Membrane Transport Modulators
(3R)-3-Hydroxy-N-[(3S)-2-oxooxolan-3-yl]butanamide
Makaluvamine I
D000970 - Antineoplastic Agents > D059003 - Topoisomerase Inhibitors > D059005 - Topoisomerase II Inhibitors D004791 - Enzyme Inhibitors
metamitron-desamino
A member of the class of 1,2,4-triazines that is metamitron in which the amino group has been replaced by a hydrogen atom. It is a metabolite of metamitron. CONFIDENCE standard compound; EAWAG_UCHEM_ID 4 EAWAG_UCHEM_ID 4; CONFIDENCE standard compound CONFIDENCE standard compound; INTERNAL_ID 2064
Benzoguanamine
CONFIDENCE standard compound; INTERNAL_ID 1063; DATASET 20200303_ENTACT_RP_MIX503; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5539; ORIGINAL_PRECURSOR_SCAN_NO 5538 CONFIDENCE standard compound; INTERNAL_ID 1063; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5533; ORIGINAL_PRECURSOR_SCAN_NO 5532 CONFIDENCE standard compound; INTERNAL_ID 1063; DATASET 20200303_ENTACT_RP_MIX503; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5545; ORIGINAL_PRECURSOR_SCAN_NO 5543 CONFIDENCE standard compound; INTERNAL_ID 1063; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5573; ORIGINAL_PRECURSOR_SCAN_NO 5572 CONFIDENCE standard compound; INTERNAL_ID 1063; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5582; ORIGINAL_PRECURSOR_SCAN_NO 5577 CONFIDENCE standard compound; INTERNAL_ID 1063; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5569; ORIGINAL_PRECURSOR_SCAN_NO 5568
1-(1-Hydroxyethyl)-4-isocyano-4-cyclopentene-1,2,3-triol
Metamitron desamino
CONFIDENCE Reference Standard (Level 1); INTERNAL_ID 82
4-Fluoro-4-aminodiphenyl
CONFIDENCE standard compound; INTERNAL_ID 1012; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7728; ORIGINAL_PRECURSOR_SCAN_NO 7723 CONFIDENCE standard compound; INTERNAL_ID 1012; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7766; ORIGINAL_PRECURSOR_SCAN_NO 7763
4,5,6,7-TETRAHYDRO-7,7-DIMETHYL-1H-PYRAZOLO[4,3-C]PYRIDINEHYDROCHLORIDE
Pyrimido[1,2-a]benzimidazol-2(1H)-one, 3,4-dihydro- (8CI,9CI)
Benzenemethanamine, 4-(difluoromethoxy)-α-methyl-, (αR)-
Pyrido[4,3:4,5]pyrrolo[1,2-a]pyrazin-1(2H)-one, 3,4-dihydro- (9CI)
(2R,5S)-5-(METHOXYCARBONYL)PIPERIDINE-2-CARBOXYLIC ACID
1-(2-methoxyethyl)-5-oxopyrrolidine-3-carboxylic acid
Tetrazolo[1,5-a]quinoxaline, 4,5-dihydro-6-methyl- (9CI)
DL-Norephedrine hydrochloride
D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D013566 - Sympathomimetics C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists D019141 - Respiratory System Agents > D014663 - Nasal Decongestants D002317 - Cardiovascular Agents > D014662 - Vasoconstrictor Agents D019440 - Anti-Obesity Agents > D001067 - Appetite Depressants
Tetrazolo[1,5-a]quinoxaline, 4,5-dihydro-5-methyl- (9CI)
1,3,5-Triazino[1,2-a]benzimidazol-2-amine,1,4-dihydro-(9CI)
Piperidine,4-(1H-pyrazol-4-yl)-, hydrochloride (1:2)
2-Methyl-2-propanyl 2-(hydroxyimino)-3-oxobutanoate
Cathine hydrochloride
D019440 - Anti-Obesity Agents > D001067 - Appetite Depressants
alpha-Fluoromethylhistidine
D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents D005765 - Gastrointestinal Agents > D000932 - Antiemetics D002491 - Central Nervous System Agents D004791 - Enzyme Inhibitors
alpha-Monofluoromethylhistidine
D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents D005765 - Gastrointestinal Agents > D000932 - Antiemetics D002491 - Central Nervous System Agents D004791 - Enzyme Inhibitors
(3-methyl-2-oxo-2,3-dihydro-1H-benzimidazol-1-yl)acetonitrile
(3R)-3-Hydroxy-N-[(3S)-2-oxooxolan-3-yl]butanamide
(2S,5S)-5-(2-carboxyethyl)pyrrolidine-2-carboxylic acid
N-acetyl-D-glutaminate
The conjugate base of N(2)-acetyl-D-glutamine; major species at pH 7.3.
6-acetamido-2-oxohexanoic acid
A member of the class of acetamides that is the acetyl derivative of 6-amino-2-oxohexanoic acid.
N-acetyl-L-glutaminate
An N(2)-acetylglutaminate that has L-configuration; major species at pH 7.3.
